期刊文献+

Ⅱ、Ⅲ期乳腺癌综合疗法对比分析(附69例报告)

Compared Analysis of Different Combined Therapies for 69 Cases of Breast Cancer with Stage Ⅱ and Ⅲ
暂未订购
导出
摘要 对Ⅱ、Ⅲ期乳腺癌69例综合方法疗效对比分析。全组5年生存率536%,Ⅱ期78%,Ⅲ期472%,Ⅱ期各组(S,S+C,S+R,S+R+C)无显著差别;Ⅲ期各组S142%,S+C33%,S+R473%,S+R+C60%(P<005)说明综合治疗方法对生存率有影响,增加放疗对Ⅲ期尤为显著;加放组淋巴区胸壁3年复发率与未加放组比为1∶2(9/50:7/19),其复发平均时间为318∶135(月),说明加放对局部控制效果的肯定。增加化疗(CMF/CAF/CEF)与未加化疗比生存率有改变,前者为595%(22/37),后者为333%(3/9),而除S组外,增加化疗使S+R+C达60%,S+R473%组无显著性差别(025>P>010)。S+(S+C)与(S+R)+(S+R+C)组5年生存率,前者为368%(7/19),后者为60%(30/50)。 Objective:To compare 69 cases of breast cancer of stage Ⅱ and Ⅲ with single or combined therapy and to analyse the result.Materials and Methods: From Feb.1984 to Oct.1990,69 cases of stage Ⅱ and Ⅲ of breast cancer were recruited and divided into 4 groups:surgery only(S),surgery+chemotherapy (S+C),surgery+radiotherapy (S+R) and surgery+radiotherapy+chemotherapy(S+R+C).Operations were undertaken as:simple mastectomy,radical mastectomy and modified mastectomy.Radiotherapy was delivered with doses of Dr 45~55 Gy/28~30 d/5~6 wk to the chest wall and to ragional lymphatic areas.Chemotherapy schedule of CMF or CAF/CEF was given for 4~6 cycles postoperatively.Results:The overall 5-year survival rate was 53 6%,e.g.stage Ⅲ 78%,stage Ⅱ47 2%.The 5-year survival rates of four groups(S,S+C,S+R and S+R+C) of stage Ⅱ were no differences( P >0 05).The 5-year survival rates of stage Ⅲ were:S 14 2%(1/7),S+C 33%(2/6),S+R 47 3%(9/19) and S+R+C 60 8% (14/23).The difference between S group and the others was statistically significant ( P <0 005).Conclusion: (1)the combined therapy especially plus radiotherapy, improve the survival rate. (2)The Tumor recurrence rate in chest wall 3-year after the operation were 9/50(plus radiotherapy)and 7/19 (no plus radiotherapy).Postoperative radiotherapy could markedly decrease the local tumor recurrence.(3)Plus chemotherapy (CMF/CAF/CEF) could change the survival rate, [59 5%(with plus chemotherapy) and 33 3% without chemoterapy)]. (4) The S+(S+C)+(S+R) and S+R+C in stage Ⅲ of 5-year survival rate were 36 8%(7/19)and 60% (30/50). (5)The 5-year survival rate of stage Ⅲ of breast cancer could be enhanced by combined therapy.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 1998年第6期76-77,共2页 Journal of Jinan University(Natural Science & Medicine Edition)
关键词 综合疗法 放疗 化疗 乳腺癌 breast cancer combined therapy radiotherapy chemotherapy
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部